Form 4 for CC Chemours Co
Accepted 2024-05-10 00:00:00 ET · period of report 2024-05-08 · accession 0001062993-24-009870 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-10 | 2024-05-08 | CC | Abbott Matthew S | Interim CFO | A - Grant | $0.00 | +11.8K | 46.1K | +34% | $0 |
| DM | 2024-05-10 | 2024-05-08 | CC | Abbott Matthew S | Interim CFO | A - Grant | $0.00 | +64.5K | 31.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-08 | A | A | 11,818 | $0.00 | 46,106.22 | D | — | — | (F1) Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units. |
| 2 | Derivative | Performance Stock Option (Right to Buy) | 2024-05-08 | A | A | 32,879 | $0.00 | 32,879 | D | $30.25 · — to 2034-05-08 | 32,879 Common Stock | (F4) Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. (F3) These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-08 | A | A | 31,614 | $0.00 | 31,614 | D | $27.50 · — to 2034-05-08 | 31,614 Common Stock | (F3) These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. |